The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Non–clear cell histology in patients with metastatic RCC as a prognostic indicator in the targeted therapy era.
Edward N. Rampersaud
No relevant relationships to disclose
Frederic Birkhauser
No relevant relationships to disclose
Joshua E Logan
No relevant relationships to disclose
Geoffrey Sonn
No relevant relationships to disclose
Yvonne Chan
No relevant relationships to disclose
Christine Anterasian
No relevant relationships to disclose
David Li
No relevant relationships to disclose
Frederic Pouliot
No relevant relationships to disclose
Fairooz F. Kabbinavar
No relevant relationships to disclose
Allan J. Pantuck
No relevant relationships to disclose
Arie S. Belldegrun
No relevant relationships to disclose